There are 449 resources available
207P - Lurbinectedin induces multimodal immune activation and augments the anti-tumor immune response in small cell lung cancer
Presenter: Triparna Sen
Session: Poster Display session
208P - The discrepancies between real-world evidence and clinical trials: A study investigating stage IV SCLC
Presenter: Luca Marzano
Session: Poster Display session
209P - Small cell lung cancer in never smokers: A descriptive analysis
Presenter: Alberto Ruano-Ravina
Session: Poster Display session
210P - Prophylactic cranial irradiation (PCI) in patients with limited-stage small cell lung cancer (LS-SCLC) in the era of magnetic resonance imaging surveillance: A systematic review and meta-analysis
Presenter: Lukas Käsmann
Session: Poster Display session
211P - Transcriptional and epigenetic landscape of neuroendocrine transformation during emergence of resistance to targeted therapies in EGFR mutant lung adenocarcinoma
Presenter: Triparna Sen
Session: Poster Display session
212P - Correlation of 68Ga-SSO120 PET with SSTR2 expression and prognostic value in patients with small cell lung cancer
Presenter: Ilektra Mavroeidi
Session: Poster Display session
213P - Comprehensive genomic atlas of small cell lung cancer finds PKD1L1 mutation associated with poor prognosis and drug susceptibility
Presenter: Haiyong Wang
Session: Poster Display session
214TiP - Tarlatamab after chemoradiotherapy in limited-stage small cell lung cancer (LS-SCLC): DeLLphi-306 (NCT06117774)
Presenter: Horst-Dieter Hummel
Session: Poster Display session
215TiP - A phase II study of durvalumab (MEDI 4736) maintenance in frail limited disease small cell lung cancer patients after thoracic chemo-radiotherapy (CRT): DURVALUNG trial
Presenter: Elisa Gobbini
Session: Poster Display session
216TiP - A phase II study of consolidation serplulimab following hypofractionated radiotherapy with concurrent chemotherapy for patients with limited stage small cell lung cancer (ASTRUM-LC01)
Presenter: Yuqi Wu
Session: Poster Display session